| Course | HS140 Pharmacology |
|---|---|
| Unit | Unit 8 |
| Paper type | Adverse effect monitoring plan |
| Length | About 890 words, 6 pages double-spaced |
| Format | APA 7 student paper |
| School | Purdue University Global |
| Program | BS in Health Science |
| Updated | October 2026 |
Free sample paper for HS140 Unit 8
Twenty Years of a Lupus Medicine and the Eye Exam That Protects Sight: A Unit 8 Adverse Effect Monitoring Plan for Hydroxychloroquine
[Student Name]
Purdue University Global
HS140: Pharmacology
Unit 8 Adverse Effect Monitoring Plan
[Instructor Name]
[Date]
The patient is composite; the screening recommendations, risk study and textbook cited are real, and no dose is prescribed by this plan.
The Patient
A composite 46-year-old woman with systemic lupus erythematosus has taken hydroxychloroquine for eight years. It controls her joint pain and skin rashes and lowers the chance of lupus flares. She weighs 60 kg, has normal kidney function and takes no other long-term medicines. She expects to stay on the drug for many more years.
Why This Drug Needs a Plan
Hydroxychloroquine is generally safe, and many side effects, such as stomach upset, are mild and early. The concern for long-term users is retinal toxicity, damage to the retina's photoreceptor cells, which turn light into nerve signals. In a large study of long-term users, the overall prevalence of retinal toxicity was 7.5 percent. Risk rose with higher daily doses relative to body weight and with longer use: at 4 to 5 mg per kilogram of real body weight per day, prevalence stayed under 2 percent within the first ten years but rose to almost 20 percent after twenty years (Melles & Marmor, 2014). Kidney disease and use of tamoxifen also raised the risk. Because early damage causes no symptoms and does not reverse when the drug stops, screening must find it before the patient notices anything.
What to Record at the Start
1. Indication and expected duration of treatment.
2. Real body weight, since risk tracks daily dose per kilogram of actual weight. The plan records the prescribed daily dose and the weight so the dose per kilogram can be calculated; deciding the dose is the prescriber's role.
3. Kidney function, because reduced function raises blood levels and risk.
4. Other medicines, especially tamoxifen.
5. An eye examination early in treatment, within its first year, to document the retina before damage could occur and to find any existing eye disease (Marmor et al., 2016).
Eye Screening Schedule
For a patient without major risk factors, current recommendations call for annual screening to begin after five years of use, using sensitive tests such as optical coherence tomography and automated visual fields rather than a routine eye check alone (Marmor et al., 2016). For patients with major risk factors, such as kidney disease, tamoxifen use or a high dose per kilogram, annual screening begins earlier. This patient has used the drug for eight years, so she should already be screened every year.
For this drug the most important safety step happens in an eye clinic, not a pharmacy or a laboratory, and it happens before any symptom appears.
What to Ask at Each Visit
1. Has she had her yearly eye screening, and when is the next one?
2. Any change in reading, such as missing letters or words, or trouble seeing in dim light? Late damage can cause these, though early damage does not.
3. Any change in weight? A large weight loss raises the dose per kilogram.
4. Any new medicines, including tamoxifen?
5. Any change in kidney function at her last blood tests?
Findings That Would Prompt Contacting the Prescriber
1. A missed or overdue eye screening.
2. Any abnormal screening result, even if she has no symptoms.
3. Weight loss that raises the daily dose above the range the prescriber intended.
4. A decline in kidney function.
5. A new prescription for tamoxifen.
Why Patients Miss Screening
Patients on hydroxychloroquine for years often feel well and see no reason for an eye appointment, especially when the drug is prescribed by a rheumatologist and the screening is done by a separate eye clinic. Referrals can lapse when insurance changes or when the patient moves. The test itself may also be unfamiliar: a standard vision check at an optometry chain does not include the sensitive scans the recommendations call for, and a patient may believe she has been screened when she has not. For this reason, the plan asks at every visit not just whether she saw an eye doctor, but whether the visit included the specialized tests, and it asks for the result to be sent to the prescriber.
How Allied Health Staff Can Help
Medical assistants and pharmacy staff are often the people who see this patient most often between specialist visits. They can check that the screening date is current, update her weight in the record at each visit so the dose per kilogram stays accurate, and flag a new tamoxifen prescription at the pharmacy counter. None of these steps requires clinical judgment, but each closes a gap that could otherwise let years of silent damage pass unnoticed.
Other Effects Worth Knowing
Hydroxychloroquine can rarely affect heart rhythm, blood sugar and skin color, and it can cause stomach upset when first started. These are discussed with the prescriber if they appear, but they are not the focus of long-term monitoring (Lilley et al., 2023).
Limits
The plan does not change her dose or replace her rheumatologist's and eye specialist's judgment. Its job is to make sure the screening happens on time and that changes in weight, kidney function or other medicines are noticed and passed on.
References
Lilley, L. L., Collins, S. R., & Snyder, J. S. (2023). Pharmacology and the nursing process (10th ed.). Elsevier.
Marmor, M. F., Kellner, U., Lai, T. Y. Y., Melles, R. B., & Mieler, W. F. (2016). Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology, 123(6), 1386-1394. https://doi.org/10.1016/j.ophtha.2016.01.058
Melles, R. B., & Marmor, M. F. (2014). The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmology, 132(12), 1453-1460. https://doi.org/10.1001/jamaophthalmol.2014.3459
What the HS140 Unit 8 assignment asks for
The eighth unit usually asks students to write a monitoring plan for a drug taken long term, covering baseline information, what to ask or measure over time, findings that should prompt contacting the prescriber and how often monitoring occurs. Three to five pages is common. Instructors look for monitoring tied to the drug's known harms and the patient's risk factors, with sources for any thresholds or schedules. A brief patient profile is usually expected, since monitoring intensity depends on who is taking the drug. Many prompts emphasize the allied health role: noticing, recording and reporting rather than changing therapy. Explaining why monitoring often fails in practice can strengthen the plan.
Inside the HS140 Unit 8 example
The plan introduces the patient and why she takes the drug. It explains retinal toxicity and its risk factors using a large study of long-term users. Baseline items are listed: indication, real body weight, kidney function, other medicines and an early eye examination. The screening schedule follows 2016 recommendations, with earlier screening for higher risk; the highlighted sentence notes that the key step happens in an eye clinic. Visit questions and reportable findings follow. Sections explain why patients miss screening and how allied health staff can help. Other effects and the plan's limits close the paper. The plan states plainly that dosing belongs to the prescriber, keeping monitoring and treatment separate.
Reading the HS140 Unit 8 grading rubric
Monitoring plans are typically assessed on relevance to the drug's real risks, use of evidence for schedules and risk factors, completeness of baseline and follow-up items, clarity of reporting triggers and respect for scope. Relevance and evidence often weigh most; a plan built on the wrong harms or unsupported intervals loses heavily. Completeness rewards including weight, kidney function and interacting drugs where they change risk. Clear triggers earn credit when each is specific and tied to action. Scope matters: plans that change doses or stop drugs without the prescriber cost points. Practical steps for allied health staff and accurate citations complete the grade. Plans that name who checks each item, and when, tend to read as more workable.
Common HS140 Unit 8 mistakes, and how to avoid them
A frequent weakness is a plan that lists every possible side effect without prioritizing the one that causes lasting harm. Another is relying on symptoms for a harm that is silent until advanced. Some students give screening intervals without a source or confuse a routine vision check with the specialized tests recommended. Others overlook weight changes, which alter the dose per kilogram. Recommending dose changes oversteps the allied health role. If your assigned drug is different, perhaps lithium or methotrexate, send the patient profile and drug, and a plan can be built around its main long-term risks. Forgetting to ask whether the specialized eye tests were actually done is another frequent gap.
Get an HS140 Unit 8 example written to your instructions
Share the drug or class your Unit 8 plan covers, the prompt, the rubric and any case notes from your instructor. Sourced parameters and escalation points fill the custom adverse effect monitoring plan you receive within 24-48h, matched to that brief. The first plan is free. Thresholds stay cited to a reference rather than invented. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
More HS140 papers and BS in Health Science samples
- HS140 Unit 1: Drug Route Discussion Post
- HS140 Unit 2: Calcium Channel Blocker Class Profile
- HS140 Unit 3: Dosage Calculation Practice Set
- HS140 Unit 4: Stable Angina Drug Case
- HS140 Unit 5: Drug Interaction Analysis
- HS140 Unit 6: Medication Near Miss Seminar Reflection
- HS140 Unit 7: Asthma Inhaler Teaching Handout
- HS140 Unit 9: Special Population Brief
- HS140 Unit 10: Medication Case Analysis
- HS111 Unit 8: MRI Report Terminology Breakdown
- HS499 Unit 8: Seminar Reflection
- HS460 Unit 8: Risk Register
HS140 Unit 8 questions, answered
Where should threshold values come from?
From the drug reference your course uses or from the order in the case, and always cited. Thresholds vary by reference and by patient, so a plan that states a number without a source is hard to grade and may be wrong. Where no figure is supplied, a bracketed placeholder noting that the value comes from the prescriber is accurate and acceptable.
Does the plan need a patient profile?
Usually a brief one, because monitoring intensity depends on who is taking the drug. An older adult on several medications needs closer watching than a healthy younger patient. Keep the profile composite and short, a few sentences on age, relevant history and other medicines, then let the plan show how each factor changes what is checked and how often.
Can I choose a different drug class?
If the prompt allows a choice, pick a class with clear, measurable adverse effects, so the plan has real parameters to track. Anticoagulants, diuretics, lithium and statins all work well. A class whose main risks are hard to measure makes for a thinner plan. Whatever you choose, the structure stays the same: mechanism, parameters, timing and escalation.
Where can I find a free HS140 Unit 8 sample paper?
The complete Unit 8 monitoring plan is posted here, organizing eye screening and reporting for long-term hydroxychloroquine in a patient with lupus.
When should eye screening for hydroxychloroquine begin?
A baseline exam early in treatment, then yearly screening after five years for most patients, or sooner with risk factors such as kidney disease or tamoxifen.